Drugs News and Research

RSS

New research at Tel Aviv University may lay groundwork for retinal implants in people

Television's Six Million Dollar Man foresaw a future when man and machine would become one. New research at Tel Aviv University is making this futuristic "vision" of bionics a reality.

23 Mar 2010

SAMHSA study shows how psychiatric drugs prescribed for medical conditions

A new study sponsored by the Substance Abuse and Mental Health Services Administration outlines the conditions that physicians around the country reported treating with psychiatric drugs such as antipsychotics, antidepressants, and anti-anxiety drugs.

23 Mar 2010

Researchers investigate link between consumption of high-fructose corn syrup and obesity

A Princeton University research team has demonstrated that all sweeteners are not equal when it comes to weight gain: Rats with access to high-fructose corn syrup gained significantly more weight than those with access to table sugar, even when their overall caloric intake was the same.

23 Mar 2010

Sir James Black inventor of beta-blockers passes away

Sir James Black passed away on Monday after a long illness, he was 85. Sir James Black is credited as the inventor of the beta-blocker drugs in 1962. These are drugs which play an important role in the treatment of angina and heart attacks. They are regarded as one of the major medical breakthroughs of the 20th Century in Pharmacology. Born in Uddingston, Lanarkshire, Sir James Black studied medicine at St. Andrews University.

23 Mar 2010

ChemGenex shares falter as FDA requests more data on new leukemia drug

ChemGenex Pharmaceuticals Ltd. Shares fell most in the last 16 years to AUD$0.44 following a concern raised by the US drug regulators – US FDA. The FDA requested on Monday for more uniform clinical test data before they review and consider approval of the company’s new leukemia drug.

23 Mar 2010

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee voted 7-1 that a validated test to identify the T315I mutation should be reviewed by the FDA prior to approval of OMAPRO™ (omacetaxine mepesuccinate).

23 Mar 2010

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.

23 Mar 2010

Some industry groups see boon in health bill

The New York Times reports that the 32 million additional Americans who would be covered by health insurance by 2019 "would mean millions more Americans buying private health insurance and better able to pay for their hospital stays, doctors' visits, prescription drugs and medical devices. And some analysts said as the vote neared that the final legislation was shaping up as much kinder to the industry than many initially feared.

23 Mar 2010

$CTI's pixantrone trial for relapsed/refractory aggressive NHL: FDA ODAC finds data inadequate for approval$

CTI's pixantrone trial for relapsed/refractory aggressive NHL: FDA ODAC finds data inadequate for approval

Cell Therapeutics, Inc. announced today that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee panel voted unanimously that clinical trial data was not adequate to support approval of pixantrone for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.

23 Mar 2010

NPAF applauds Congressional Democrats for supporting health insurance reform

The National Patient Advocate Foundation -- a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels -- today praised Congressional Democrats for their courageous support of health insurance reform that will expand health insurance coverage and restrict the ability of insurance companies to deny coverage based on pre-existing conditions.

23 Mar 2010

How the health bill would affect you

Kaiser Health News has a Q & A for consumers, detailing who would have to get health insurance, what programs are available to help them afford it and how the legislation would affect seniors and young adults (Galewitz, 3/21).

23 Mar 2010

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Scientists at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center were awarded a five-year $7.5 million grant to tease apart - in the most comprehensive way ever devised -the role of a single protein receptor in breast cells in cancer development and treatment.

22 Mar 2010

Pharmacy provisions in health care reform bill will help pharmacists improve patient outcomes: NCPA

Pharmacy provisions included in health care reform legislation passed by the U.S. House of Representatives will improve community pharmacists' ability to improve patient outcomes and reduce costs, the National Community Pharmacists Association said today.

22 Mar 2010

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced the pending commercial launch of 13 new SFDA approved products over the next few quarters.

22 Mar 2010

Patient dosing in CyDex Pharmaceuticals' Phase 2A clinical trial of CDX-353 initiated

CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company’s Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.

22 Mar 2010

JDRF, Pfizer, Hadassah Medical Organization, The Hebrew University of Jerusalem form diabetes research collaboration

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.

22 Mar 2010

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

Cancer Research Technology has announced an exclusive agreement with Cephalon, Inc., an international biotechnology company, to collaborate on the development of small molecule inhibitors. These molecules will target specific members of the 'protein kinase C' superfamily of cell signalling proteins - which have been shown to be associated with the development of cancer.

22 Mar 2010

ChemoCentryx undertakes Phase II clinical trial of CCX140

ChemoCentryx, Inc., today announced that it has undertaken a Phase II clinical trial of CCX140, a novel, orally-available small molecule compound designed to specifically target the chemokine receptor known as CCR2.

22 Mar 2010

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

Medical Facilities Corporation, today reported its financial results for the three and twelve-month periods ended December 31, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.

22 Mar 2010

AARP Maryland commends Representatives who voted for health care reform

The U.S. House of Representatives voted late Sunday to move forward with a package of health care reforms that will bring needed relief to millions of Americans struggling with the high cost of prescription drugs and discriminatory insurance company practices. By passing this legislative package, Members voted to protect and improve the guaranteed benefits that people in Medicare rely on and make progress toward ending the rampant discrimination used by insurers to deny coverage to those who need it most.

22 Mar 2010

Drugs News and Research

New research at Tel Aviv University may lay groundwork for retinal implants in people

SAMHSA study shows how psychiatric drugs prescribed for medical conditions

Researchers investigate link between consumption of high-fructose corn syrup and obesity

Sir James Black inventor of beta-blockers passes away

ChemGenex shares falter as FDA requests more data on new leukemia drug

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

Some industry groups see boon in health bill

CTI's pixantrone trial for relapsed/refractory aggressive NHL: FDA ODAC finds data inadequate for approval

NPAF applauds Congressional Democrats for supporting health insurance reform

How the health bill would affect you

GUMC scientists awarded five-year $7.5M grant to perfect treatment of breast cancer

Pharmacy provisions in health care reform bill will help pharmacists improve patient outcomes: NCPA

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

Patient dosing in CyDex Pharmaceuticals' Phase 2A clinical trial of CDX-353 initiated

JDRF, Pfizer, Hadassah Medical Organization, The Hebrew University of Jerusalem form diabetes research collaboration

CRT, Cephalon to collaborate on development of small molecule inhibitors against cancer

ChemoCentryx undertakes Phase II clinical trial of CCX140

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

AARP Maryland commends Representatives who voted for health care reform

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News